Next-generation drug from Eli Lilly boosts weight loss to 24% ... - CNN
Jun 26, 2023 · An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss...
FDA approves Zepbound, a new obesity drug that will take on …
Nov 8, 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
Beyond Ozempic: New GLP-1 drugs promise weight loss and …
The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro...
Questions and answers about the new anti-obesity medications
Jan 1, 2024 · A blockbuster batch of anti-obesity drugs continues to grab headlines and dominate social media posts, and not just because the new year revs up our resolve to shed pounds. The medications — semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound) — are backed by science and stunning accounts of people losing as much as 20% ...
FDA declares the shortage of obesity drug ... - Health News Florida
Dec 28, 2024 · The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. And like Ozempic and Wegovy, Zepbound has been in short supply because of high demand. The Food and Drug Administration declared it resolved last week. NPR pharmaceuticals correspondent Sydney Lupkin joins us.
New Obesity Drug MariTide Helps Patients Lose Up to 20% of …
Nov 26, 2024 · The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 percent of their weight in a year. The drug, MariTide, is given by...
Why the Obesity Drug Revolution Is a Work in Progress
4 days ago · A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies ...
Beyond Ozempic: Trials Hold Promise of Highly Effective Obesity Drugs
Jun 30, 2023 · Semaglutide, also known by its brand names Ozempic and Wegovy, marks a new era in anti-obesity therapeutics. The unprecedented drug offers a safe and effective option for patients that addresses the root of obesity.
The Coming Wave of New Obesity-Treatment Drugs - Bloomberg.com
Dec 13, 2024 · Until now, just two companies have dominated the obesity-treatment market: Denmark’s Novo Nordisk A/S and its US rival Eli Lilly & Co. Ozempic and Wegovy, made by Novo, are on track to become the...
Merck moves into obesity with deal for Hansoh’s GLP-1 pill
Dec 18, 2024 · Dive Brief: Merck & Co. has made its first big move in obesity treatment, announcing Wednesday it is paying Hansoh Pharma $112 million for rights outside China to a preclinical pill that works similarly to the popular injection Wegovy. Per deal terms, China-based Hansoh could receive up to $1.9 billion in additional payouts based on reaching clinical, regulatory and commercial milestones.